Insights

Key Personnel Change EndoStim recently appointed Eric B. Goorno as President and Chief Executive Officer, showcasing a new leadership direction that may present networking and partnership opportunities for sales professionals.

Funding and Expansion EndoStim's successful history of financing, with recent debt financing and a substantial $25 million Series D funding, indicates a strong financial standing that could lead to potential collaborations and investment opportunities for sales growth.

Innovative Technology EndoStim's innovative technology for treating GERD offers a unique solution addressing a prevalent health issue, creating a market niche that could attract partnerships, licensing deals, and sales agreements with healthcare providers and institutions.

Competitive Landscape EndoStim's position among similar companies such as Obalon Therapeutics and BlueWind Medical, with a focus on a specific medical condition and a revenue range that aligns with market leaders, suggests opportunities for strategic alliances, competitive positioning, and market penetration.

Industry Expansion EndoStim's location in the U.S. healthcare hub of Dallas, coupled with a compact yet efficient team, presents opportunities for localized business development, partnerships with local healthcare facilities, and targeted sales strategies within the medical equipment manufacturing sector.

Similar companies to EndoStim

EndoStim Tech Stack

EndoStim uses 8 technology products and services including Sucuri, Google Font API, Font Awesome, and more. Explore EndoStim's tech stack below.

Sucuri
Content Delivery Network
Google Font API
Font Scripts
Font Awesome
Font Scripts
jQuery Migrate
Javascript Libraries
jQuery
Javascript Libraries
PHP
Programming Languages
X-XSS-Protection
Security
Bootstrap
UI Frameworks

Media & News

EndoStim's Email Address Formats

EndoStim uses at least 1 format(s):

EndoStim Email Formats	Example	Percentage
FLast@endostim.com	JDoe@endostim.com	46%
FMiddleLast@endostim.com	JMichaelDoe@endostim.com	4%
FL@endostim.com	JD@endostim.com	4%
FLast@endostim.com	JDoe@endostim.com	46%

Frequently Asked Questions

Where is EndoStim's headquarters located?

EndoStim's main headquarters is located at 4101 McEwen Road, Suite 336 Dallas, TX 75244 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is EndoStim's phone number?

You can contact EndoStim's main corporate office by phone at

+1-314-615-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is EndoStim's official website and social media links?

EndoStim's official website is endostim.com and has social profiles on LinkedIn.

What is EndoStim's SIC code NAICS code?

EndoStim's SIC code is 3841 - Surgical and Medical Instruments and Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does EndoStim have currently?

As of January 2020, EndoStim has approximately 30 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Head Of Sales Medical Apac: E. L.President And Ceo: E. G.Director / Ex Chief Executive Officer: B. H.. Explore EndoStim's employee directory with LeadIQ.

What industry does EndoStim belong to?

EndoStim operates in the Medical Equipment Manufacturing industry.

What technology does EndoStim use?

EndoStim's tech stack includes SucuriGoogle Font APIFont AwesomejQuery MigratejQueryPHPX-XSS-ProtectionBootstrap.

What is EndoStim's email format?

EndoStim's email format typically follows the pattern of . Find more EndoStim email formats with LeadIQ.

How much funding has EndoStim raised to date?

As of January 2020, EndoStim has raised $7M in funding. .

When was EndoStim founded?

EndoStim was founded in 2009.

EndoStim

Medical Equipment ManufacturingTexas, United States11-50 Employees

EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs).  EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease -- namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.